Promoting the Stroke Prevention Project, National Health Commission: current status and strategy of stroke prevention and treatment in China

doi:10.3969/j.issn.1006-7795.2025.01.003

Abstract

Abstract: In China, stroke has become a major public health issue. In response to the growing high-risk population and the substantial health and economic burden, the National Health Commission initiated “the Stroke Prevention Project, National Health Commission” in 2021. This program aims to systematically enhance the stroke prevention and control capacities, therebyreducing the harm caused by stroke. This report offers an overview of the program’s background and strategic implementation from a policy and governance perspective.

Key words: stroke;prevention and control system, first aid for stroke, the Stroke Prevention Project, National Health Commission, construction of stroke center

CLC Number:

R743

Stroke Prevention Project, National Health Commission, Ji Xunming. Promoting the Stroke Prevention Project, National Health Commission: current status and strategy of stroke prevention and treatment in China[J]. Journal of Capital Medical University, 2025, 46(1): 11-14.

0
/ Save 0 / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2025.01.003

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2025/V46/I1/11

References

［1］ Martin S S, Aday A W, Almarzooq Z I, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association［J］. Circulation, 2024, 149(8): e347-e913.
［2］《中国卒中中心报告2022》编写组.《中国卒中中心报告2022》概要［J］. 中国脑血管病杂志, 2024, 21(8): 565-576.
［3］ Tu W J, Wang L D, Special Writing Group of China Stroke Surveillance Report. China stroke surveillance report 2021［J］. Mil Med Res, 2023, 10(1): 33.
［4］ Roth G A, Mensah G A, Johnson C O, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study［J］. J Am Coll Cardiol, 2020, 76(25): 2982-3021.
［5］中国脑卒中防治:成就、挑战和应对［J/OL］. 中国循环杂志, 2019, 34(7): 625-631［2024-10-12］.http://www.chinacirculation.org/#/browse_details?year=2019&issue=7&issuecid=136713.
［6］中华人民共和国国家卫生健康委员会. 加强脑卒中防治工作减少百万新发残疾工程综合方案［J］. 中国实用乡村医生杂志,2021,28(9):11-14.
［7］国务院办公厅.国务院办公厅关于推进医疗联合体建设和发展的指导意见［J］. 中华人民共和国国务院公报,2017(13):14-18.
［8］中华人民共和国国家卫生健康委员会. 医疗联合体管理办法(试行)［J］. 中国实用乡村医生杂志,2020,27(8):4-7.
［9］胡琼丹, 陈霞, 高春鹏. 219所医院脑心健康管理师工作开展和资源配置现况调查［J］. 护理实践与研究, 2023, 20(11): 1586-1593.
［10］胡琼丹, 陈霞, 曹教育, 等. 脑心健康管理师主导脑卒中风险筛查门诊的实践效果［J］. 护理学杂志, 2022, 37(9): 38-41.
［11］杨彩侠, 刘延锦, 郭园丽, 等. 脑心健康管理师主导的缺血性卒中患者全流程健康管理［J］. 护理学杂志, 2020, 35(21): 36-39.
［12］杨彩侠, 刘延锦, 郭园丽, 等. 脑心健康管理师结合全流程管理对脑卒中患者康复进程、心理状态及社会功能的影响［J］. 齐鲁护理杂志, 2021, 27(5): 40-42.
［13］ Wang S, Li Y, Tian J, et al. A randomized controlled trial of brain and heart health manager-led mHealth secondary stroke prevention［J］. Cardiovasc Diagn Ther, 2020, 10(5): 1192-1199.

[1]	Yang Xiao, Meng Yuanyuan, Yang Jingyi, Wang Shuhan, Zhang Ligong. Predictive value of atherogenic index of plasma index, triglyceride-glucose index and cerebral small vascular disease imaging markers on early neurological response after intravenous thrombolysis in patients with acute ischemic stroke [J]. Journal of Capital Medical University, 0, (): 48-55.
[2]	Zhang Meng, Ma Yongxin, Jia Qiong , Zhang Dongwei, Zhang Xinhong, Xu Yaoming . Clinical observation on the efficacy and safety of intravenous thrombolysis in the treatment of acute mild non-disabling ischemic stroke: a single-center retrospective observational study [J]. Journal of Capital Medical University, 2025, 46(1): 56-62.
[3]	Liu Xiaomeng, Zhou Shaojuan, Shao Xiaohong, Xu Wenping, Huan Feng, Zhu Xiangyang. Current situation and four-level prevention of stroke under the collaborative management model between medical prevention and treatment in Nantong [J]. Journal of Capital Medical University, 2025, 46(1): 63-67.
[4]	Qiao Yue, Li Chuanhui, Zhao Wenbo. The current status and future directions of reperfusion therapy for acute ischemic stroke [J]. Journal of Capital Medical University, 2025, 46(1): 68-70.
[5]	Guo Yibing, Meng Ran. Research advances on lipoprotein(a) in cerebrovascular diseases [J]. Journal of Capital Medical University, 2025, 46(1): 71-75.
[6]	Cui Wei, Pang Qidan, Xiang Hanyue, Xiao Nao, Jiang Dechun, Li Shen, Shen Guangli. Detection of cerebral ischemia-reperfusion injury using BIBP-H fluorescent probe [J]. Journal of Capital Medical University, 2025, 46(1): 76-82.
[7]	Ya• Naren, Liu Yan, Zhou Xia, Zhu Dekun, Chen Feng, Ma Zhengfei, Li Chuanhui, Sun Zhongwu. Cerebral angiographic features and prognostic study in patients with central retinal artery occlusion [J]. Journal of Capital Medical University, 2025, 46(1): 15-21.
[8]	Chu Xuehong, Shen Yingjie, Wang Yaolou, Dong Xiao, Liu Yuanyuan, Feng Yan, Jiang Miaowen, Li Ming, Ji Xunming, Wu Chuanjie. Exploring the causal relationship between extensive perivascular space burden and ischemic stroke and its subtypes and transient ischemic attack based on Mendelian randomization [J]. Journal of Capital Medical University, 2025, 46(1): 22-33.
[9]	Wang Yinping, Meng Cancan, Wu Wenjuan, Yang Zhitang. The expressions of CD62P, CD40L, and Rev-erbα after ischemic stroke on different onset times [J]. Journal of Capital Medical University, 2025, 46(1): 34-40.
[10]	Zhan Yanli, Li Yiyin, Li Ping, Sun Jingping, Huang Liangtong, Cai Xueli. Analysis of the current status and efficacy of acute ischemic stroke treatment based on hierarchical medical service network [J]. Journal of Capital Medical University, 2025, 46(1): 41-47.
[11]	An Qi, Yang Nan, Zhu Yuequan, Shi Wenjuan, Huang Minqi, Zhao Yongmei. Effect of autophagy inhibitor 3-MA on inflammatory response in the brain of rats with cerebral ischemia/reperfusion injury [J]. Journal of Capital Medical University, 2024, 45(6): 1008-1015.
[12]	Li Yakun, Li Wei, Yang Xueqi, Shi Wenjuan, Zhu Yuequan, Zhao Yongmei. Effect of mitochondrial reactive oxygen species inhibitor EUK-134 on mitochondrial associated proteins PGC-1α and VDAC1 in rats with cerebral ischemia-reperfusion injury [J]. Journal of Capital Medical University, 2024, 45(6): 1016-1022.
[13]	Liu Yang, Gao Chao, Wang Xiaojie, Zhang Liang, Wu Anshi. Effect of remimazolam and propofol on postoperative delirium in elderly patients undergoing cerebral endovascular surgery [J]. Journal of Capital Medical University, 2024, 45(6): 1023-1028.
[14]	Li Xingmao, Li Xiu, Wang Ting, Zhao Xin, Wang Deyang, Shang Haiyan, Zhao Yongmei, Li Sen. Effects of GLP-1 receptor agonists on cognitive function in patients with type 2 diabetes mellitus after acute ischemic stroke [J]. Journal of Capital Medical University, 2024, 45(6): 1029-1037.
[15]	Shen Tong, Li Fangfang, Fan Junfen, Luo Yumin. Correlation analysis of plasma YAP level with stroke prognostic factors and post-stroke inflammation [J]. Journal of Capital Medical University, 2024, 45(6): 1071-1078.